Table 1.
Clinical parameters of tumor samples analyzed by RT-PCR
| Tumor Number | Age, y | Sex | Diagnosis |
|---|---|---|---|
| LGA01 | 58 | F | LGA |
| LGA02 | 24 | M | LGA |
| LGA03 | 54 | M | LGA |
| LGA04 | 3 | M | LGAa |
| LGA05 | 12 | F | LGAa,b |
| LGA06 | 34 | M | LGA |
| LGA07 | 34 | M | LGA |
| LGA08 | 40 | F | LGA |
| GBM01 | 54 | F | GBMc |
| GBM02 | 18 | F | GBMa |
| GBM03 | 68 | M | GBM |
| GBM04 | 60 | M | GBM |
| GBM05 | 65 | M | GBM |
| GBM06 | 41 | M | GBMa |
| GBM07 | 69 | M | GBM |
| GBM08 | 62 | M | GBM |
| GBM09 | 62 | F | GBMd |
| GBM10 | 62 | F | GBM |
| GBM11 | 59 | F | GBM |
| GBM12 | 12 | F | GBM |
| GBM13 | 65 | M | GBM |
| GBM14 | 79 | M | GBM |
| GBM15 | 53 | M | GBM |
Diagnosis of the patients: LGA WHO grade II and GBM. If not stated otherwise, all samples are from initial surgery of primary tumor prior to treatment.
aNo information available about preceding surgery or treatment.
bProtoplasmatic astrocytoma.
cSample from recurrent tumor, treated by γ-irradiation and chemotherapy prior to surgery.
dSample from recurrent tumor, no information about additional therapy available.